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In recent years, the need for a lead-removal technique has increased. Various extraction devices for
traction and dissection are used worldwide, and quite a few of these devices are available in Japan. This
paper details our experience using a new tool for manual dissection during transvenous pacing
lead extraction. Five leads from 4 patients were considered for extraction using a new tool, the Amplatz
renal dilator (Cook Ireland Ltd., Limerick, Ireland). The dilator was advanced following the lead course,
similar to the over-the-wire technique. From 2 (50%) of the patients, 2 leads were extracted successfully
using this procedure. No complications occurred in any of the patients. The remaining 3 leads could not
be removed due to 2 reasons: ﬁrst, the lead was entrapped in the supra vena cava, and second, the new
dissection tool could not be inserted into the implant vein because of the tight space under the clavicle.
Although the Amplatz renal dilator was useful for dissection, it was not sufﬁcient for achieving
complete procedural success. Our experience suggests that the Amplatz renal dilator can be a feasible
and safe option for low-risk manual dissection in transvenous pacing lead extraction.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Recently, the need for a cardiovascular implantable electronic
device (CIED) for lead removal in patients has increased due to
several factors, such as lead failure, infection, lead–lead interactions,
venous stenosis or thrombosis, chronic pain at the device- or lead-
insertion site, life-threatening arrhythmias secondary to retained
leads, and the need to upgrade to a new technology [1,2]. The
2 major drawbacks of lead removal are traction to the tip of the lead
and problems dissecting the ﬁbrotic attachments of the lead from the
surrounding tissues and vessel walls [3]. Various extraction devices
for traction and dissection are used worldwide, with several of these
devices being available in Japan. In this report, we present ﬁndings
using a new tool for dissection in transvenous pacing lead extraction.
1.1. Case reports
Between 2000 and 2011, several procedures of transvenous lead
removal were attempted for 33 leads in 20 patients, of which 771
procedures involved CIEDs. The success rate with simple traction
was 64% (21 leads). Of the 12 leads from the failed explants, 5 leads
from 4 patients were considered for extraction using the newrt Rhythm Society. Published by E
x: þ81 564 25 5531.extraction tool, the Amplatz renal dilator (Cook Ireland Ltd.,
Limerick, Ireland), for manual dissection of the ﬁbrotic adhesion
from the venous wall and atrial endocardium. These 5 leads were
pacing leads without inclusion of an implantable cardiac deﬁbrilla-
tor lead and a coronary sinus lead. Data for these 5 leads are
summarized in Table 1. Four non-functional leads and 1 lead that
caused pocket infection were indicated for extraction.
1.2. Extraction tool
The new extraction tool, the Amplatz renal dilator (Fig. 1), is
30 cm in length, has an inner and outer diameter of 8 F and 12 F
or 14 F, respectively. The tip of this dilator is rounded and tapered
for gentle dilatation of a percutaneous renal ﬁstula. The optimal
thickness and intensity of this new tool might provide a safer
blunt dissection compared with techniques using various other
sheaths for lead extraction.
1.3. Extraction procedure
Lead extraction was performed in an operating room using a
mobile C-arm ﬂuoroscopic x-ray machine. In 3 patients, this
procedure was carried out under general anesthesia, while in
1 patient, it was carried out under local and venous anesthesia.
The patients were prepared for the procedure with application oflsevier B.V. All rights reserved.
Table 1
Patient characteristics and outcome.
Patient 1 2 3 4 ’
Age (years) 74 84 76 65 ’
Sex Female Male Male Female ’
Anesthesia General Local and venous General General ’
Postoperative complications () () () () ’
Targeted lead 1 2 3 4 5
Indication for removal Infection Non-functional Non-functional Non-functional Non-functional
Class of indication [1] I 2 IIb 1 IIb 1 IIa 2 IIa 2
Lead implant period (months) 180 141 212 218 218
Lead body diameter (mm) 2.4 1.9 2.6 2.6 2.4
Lead location RV RV RA RA RV
Type of tip Tined Tined Tined Tined Tined
Result Success Success Failure Failure Failure
Cause of failure – – Entrapped No insertion ’
RA: right atrium, RV: right ventricle.
Fig. 1. Amplatz renal dilator.
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pressure and pulse oximetry monitoring.
Once the patient was prepared, the pulse generator pocket was
opened and, using scissors, the leads were freed from their adhe-
sions down to the implant vein as far as possible. The leads were
then cut at the edge of the access point, and for manual traction,
the suture material was secured by tying once. A standard stylet,
supplied by the lead manufacturer, was introduced into the lead
body, with its tip oriented as close as possible to the lead tip, in
order to stiffen it. Once the lead was freed and secured, gentle
manual traction was applied in an attempt to remove the lead.
When the manual traction failed to remove the lead, we used this
new technique. To reach the targeted lead, dissection was performed
using the Amplatz renal dilator. Traction was maintained on the
suture tie, while the dilator was advanced, following the lead course,
in a manner similar to over-the-wire technique. While dissecting,
smooth traction was performed, in order to keep tension on the lead,
while simultaneously avoiding invagination of the myocardium and
the venous wall or coil lengthening and lead damage. As the dilator
was 30 cm in length, manual traction was performed again when
the dilator neared the tricuspid valve. Once the tip was freed, the
lead and the dilator were removed through the implant vein.2. Results
Of the 5 leads to be removed from 4 patients, 2 leads were
removed completely from 2 of the patients (50%) using the Amplatzrenal dilator for lead extraction. No complications were seen in any
patient on whom the new extraction tool was used. The remaining
3 leads could not be removed because of 2 reasons. The ﬁrst reason
was that in 1 patient, the lead was entrapped in the supra vena cava
and could not be slipped through. The second reason was the new
dissection tool could not be inserted into the implant vein of the other
patient because of the tight space between the clavicle and the ﬁrst
rib. Although the Amplatz renal dilator was useful for dissection, it
was not sufﬁcient to achieve complete procedural success.3. Discussion
The keys to a successful CIED lead removal were traction,
dissection, and complete retrieval through the implant vein,
without injury of the venous system and the myocardium. High
success and low complication rates were achieved by avoiding the
use of excessive force or powered sheaths to overcome tight
binding sites [3]. This new tool is one of the mechanical sheaths
used for blunt dissection, but unlike a rotating threaded tip
sheath [4–6], electrosurgical sheath [3], and a laser sheath [7],
it cannot be used to perform sharp dissection.
3.1. Tool characteristics and limitations
The 8 F inner diameter of the Amplatz renal dilator with the
outer sheath used for dissection is close to the targeted lead body
diameter. This means that the gap between the lead and the
Amplatz renal dilator is small. This can help avoid venous and
myocardial wall invagination with the gap, which can cause
injury to the venous and myocardial systems and can result in
life-threatening complications. The tapering tip and rounded
shape of this new tool allows for the application of gentle manual
pressure to the ﬁbrotic adhesional tissues and for blunt dissec-
tion. The ﬂexibility of the new tool aided in easy advancement
along the course of the targeted lead, particularly at the junction
of the innominate vein and supra vena cava, which is a dangerous
area for powered sheaths [3]. These characteristics of the tool
make CIED lead removal a safe procedure.
This new tool has 3 limitations in lead extraction. The ﬁrst is
that the new tool is available only for blunt dissection. In
2 patients, the new dissection tool could not be inserted into the
implant vein because of the tight space between the clavicle and
the ﬁrst rib. In these cases, devices with sharp dissection mechan-
isms, to facilitate venous access, are useful [4–7]. These devices
can cut adhesions and advance through extensively scarred or
calciﬁed tissues under the clavicle. The second limitation is that
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from the left subclavian vein. Therefore, it could not be used as a
counter traction tool for the removal of the tip of a ventricular lead
[5] or for the dissection of the intraventricular and coronary sinus
adhesions. Finally, this tool cannot advance, following the course
of the targeted lead, with an outer diameter of over 8 F.
This tool is useful but has limitations, as listed above. There-
fore, this system is useful only in speciﬁc situations, like when the
targeted leads have been implanted for relatively short durations,
or when the patients cannot move easily because of social or
medical situations. A laser extraction system that is already
available in Japan is more useful.
3.2. Improvement in success rate on using the other techniques
The introduction of locking stylets to improve tensile properties
during traction [6] and grasping devices coupled with endovascular
techniques could help to free the tip of the targeted lead. We could
not slip a freed tip through the targeted lead because the entrapped
lead had stuck to the supra vena cava in 1 patient. In this case, the
free-ﬂoating distal portion of the lead was removed using grasping
devices. It has been reported that various endovascular techniques,
such as multiple venous approaches [3], were useful in accomplish-
ing complete procedural success in the presence of a free-ﬂoating
lead or an entrapped lead within the venous system.
Despite the facility and cost-effectiveness of this procedure, our
ﬁndings suggest that this approach can be achieved ideally using a
cardiology team that includes cardiologists, cardiothoracic surgeons,
anesthesiologists, and experienced technicians on standby to cope
with any complications, in a hybrid operating room equipped for athoracotomy and containing a high-quality ﬂuoroscopic x-ray
machine to guide the procedure and a clean environment to implant
the CIEDs.
In conclusion, our experience suggests that the Amplatz renal
dilator can be an economical, feasible, and safe manual dissection
tool for carrying out low-risk transvenous pacing lead extraction.Conﬂict of interest
No conﬂict of interest was associated with this study.
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